Day 2 ADA

[itellthefuture777]

www.trendsmap.com/twitter/tweet/1272197409796390912

 
We’re excited for another day here at #ADA2020! Today we will be sharing our @mannkindcorp oral presentation at 5:30pm CT. To view the abstract for OR-235, visit bit.ly/3dYLh3g. #ADAGoesVirtual

[rfogel]

If I were diabetic, I don't know that I would find that conclusion -- "persistent significant decline in FEV1 during the use of TI was uncommon" -- very reassuring. The study also doesn't specify the doses so there's no way of knowing whether higher doses may have contributed to the FEV changes.

[bill]

Jun 15, 2020 14:23:28 GMT -5 rfogel said:

If I were diabetic, I don't know that I would find that conclusion -- "persistent significant decline in FEV1 during the use of TI was uncommon" -- very reassuring. The study also doesn't specify the doses so there's no way of knowing whether higher doses may have contributed to the FEV changes.

Gotta love the way people write in ways that confuse and obfuscate. They could have said something like "it was uncommon to see any persistent significant decline in FEV during use of TI." Of course, it begs the question of why "persistent" and "significant" were even important, i.e., what did the data show that made this observation report worthy.